Zhou Xianfeng, Liu Bin, Yu Xianghui, Zha Xiao, Zhang Xizhen, Chen Yu, Wang Xueyun, Jin Yinghua, Wu Yongge, Chen Yue, Shan Yaming, Chen Yan, Liu Junqiu, Kong Wei, Shen Jiacong
College of Life Science, Jilin University, Changchun 130012, PR China.
J Control Release. 2007 Aug 28;121(3):200-7. doi: 10.1016/j.jconrel.2007.05.018. Epub 2007 May 25.
A novel approach involving the preparation of mannose-bearing chitosan microspheres with entrapping complexes of HBV DNA and PEI was developed to improve the delivery of DNA into antigen-presenting cells (APCs) after intramuscular (i.m.) injection. Compared with the traditional chitosan microspheres, the microspheres could quickly release intact and penetrative PEI/DNA complexes. What's more, chitosan was modified with mannose to target the primary APCs such as dendritic cells (DCs) owing to the high density of mannose receptors expressing on the surface of immature DCs. After i.m. immunization, the microspheres induced significantly enhanced serum antibody and cytotoxic T lymphocyte (CTL) responses in comparison to naked DNA.
开发了一种新方法,即制备负载甘露糖的壳聚糖微球,并将乙肝病毒(HBV)DNA与聚乙烯亚胺(PEI)的包合物包封其中,以改善肌内注射后DNA向抗原呈递细胞(APC)的递送。与传统壳聚糖微球相比,这种微球能够快速释放完整且具有穿透性的PEI/DNA复合物。此外,壳聚糖用甘露糖修饰,由于未成熟树突状细胞(DC)表面表达的甘露糖受体密度高,可靶向主要的APC,如DC。肌内免疫后,与裸DNA相比,这种微球诱导的血清抗体和细胞毒性T淋巴细胞(CTL)反应显著增强。